Pin1 as a marker for abnormal cell growth
AssigneePintex Pharmaceuticals, Inc.
InventorsDa Gong Wang, Lere Bao
Life of this patent
Estimating the term…
Abstract
Methods for the use of Pin1 as a marker of abnormal cell growth are disclosed. In one embodiment, the method includes detecting a level of Pin1 to stage an abnormal cell growth, such as breast or prostate cancer. In another embodiment, the method includes evaluating the efficacy of a treatment of an abnormal cell growth, such as cancer, by monitoring the levels of Pin1. In another embodiment, the method includes evaluating the extent of metastasis of abnormal cell growth, such as cancer. The levels of Pin1 can be protein levels or nucleic acid levels.
Claims48
A method of detecting abnormal cell growth in a mammal, comprising assessing the level of Pin1 in a test sample from the mammal, wherein an elevation in the levels of Pin1 is indicative of abnormal cell growth.
A method of determining the stage of cancer in a test sample from a mammal, comprising assessing a level of Pin1 in the test sample, wherein the level of Pin1 correlates with the stage of the cancer.
A method of evaluating the efficacy of a treatment of abnormal cell growth in a mammal, comprising comparing a level of Pin1 in at least two test samples, wherein the test samples comprise a first test sample obtained at a first time and a second test sample obtained at a later second time, wherein a decrease in the level of Pin1 between the two test samples indicates the efficacy of the treatment of the abnormal cell growth in the mammal.
A kit for determining the level of Pin1 in a test sample from a mammal comprising one or more reagents for detecting Pin1.
A method for determining whether a subject having cancer is likely to respond to treatment comprising a Pin1 inhibitor compound, the method comprising:
- assessing the level of Pin1 in a test sample from the subject;
- and
- comparing the level of Pin1 in the test sample to the level of Pin1 in normal tissue, whereby an increased level of Pin1 in the test sample is indicative that the subject is likely to respond to treatment comprising a Pin1 inhibitor compound.
A method of treating an individual suffering from cancer comprising, administering to said individaul a Pin1 inhibitor such that treatment occurs.
Dependencies are inferred from the claim text.